Stay updated on Switching to Cabotegravir and Rilpivirine: Clinical Trial

Sign up to get notified when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Switching to Cabotegravir and Rilpivirine: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.3%
    Check dated 2025-02-10T09:54:02.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.0%
    Check dated 2025-02-03T08:27:30.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The study has added 113 locations across various countries, including new entries in Argentina, Canada, France, Germany, Italy, South Korea, Mexico, Russia, South Africa, Spain, and Sweden, while removing 115 locations from the previous list, indicating a significant update in the geographical scope of the study.
    Difference
    4%
    Check dated 2025-01-27T03:22:55.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-19T22:11:09.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.
    Difference
    0.0%
    Check dated 2025-01-12T17:43:22.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.0%
    Check dated 2024-12-14T22:39:37.000Z thumbnail image

Stay in the know with updates to Switching to Cabotegravir and Rilpivirine: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.